The FDA and CDC pause the Johnson and Johnson vaccine

The+CDC+and+the+FDA+both+recommended+to+put+a+temporary+%E2%80%9Cpause%E2%80%9D+on+the+Johnson+and+Johnson+vaccine.+

Courtesy of Creative Commons

The CDC and the FDA both recommended to put a temporary “pause” on the Johnson and Johnson vaccine.

Jamie Adams, Staff Writer

For many Americans the presence of this pandemic is still causing fear to be at an all time high. Many thought this would be a short term virus, impacting our lives for only a few months. Now a year later, the virus is still as frightening as ever.

To try and reduce the spread, vaccines have now been developed and distributed for about three months. Many were hesitant because of the rapid development of these vaccines, while many were relieved and quick to get vaccinated to protect themselves and others.

One major concern many had with the vaccines was their lack of longitudinal studies. Vaccines tend to take years to develop and many clinical trials. Because of the high demand and need for them, the COVID vaccines were distributed at rapid rates. Researchers and scientists stood behind the vaccines, which put many Americans at ease and left many excited for a gradual return to normalcy.

With many people becoming vaccinated responses and opinions differed. Americans were given options of three different vaccines: Moderna, Johnson and Johnson, and the Pfeizer vaccines. Individuals were to choose which type they wanted to receive.

Moderna and Pfeizer seemed to be liked without adverse effects. Johnson and Johnson on the other hand had a significant side effect causing the Food and Drug Administration (FDA) to put the vaccine on hold. According to the FDA, “It was reported that six women who were given the Johnson and Johnson vaccine developed blood clots afterwards.”

The Centers for Disease Control and Prevention (CDC) principal deputy director, Dr. Anne Schuchat, states that,“The clots that have been reported so far have been in women between the ages of eighteen and forty eight.” Their symptoms were experienced thirteen days after becoming vaccinated.

Out of the six individuals who developed the blood clots, one was fatal and one is still in critical care. This type of blood clot is called cerebral venus sinus thrombosis, which is located in the blood supply that drains the brain. Symptoms include headaches, blurred vision, fainting or loss of consciousness, loss of motor control, and seizures.

While this may be such a small number in relation to the seven million individuals who received this vaccine, these side effects have left Americans hesitant and unsure.

Victoria Mueller, a senior at Stephen Decatur was scheduled to get her COVID vaccine this past week. With the Johnson and Johnson vaccination being ‘paused,’ she was hesitant and even ending up canceling her appointment. Mueller states, “I was not even scheduled to receive the Johnson and Johnson vaccine as I was getting Moderna, but researchers stopping it from being distributed made me fearful, essentially, leaving me frightened to even receive one at all.”

Americans now are faced with a tough decision to remain getting vaccinated, or to let the six out of seven million odd chances change their minds. Individuals must decide if they feel that the benefits outweigh the risks.